miRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia

Objective. The objective of this study was to evaluate the molecular mechanism by which Qianliening capsule (QC) treats benign prostatic hyperplasia (BPH). Methods. Benign prostatic hyperplasia epithelial cell line BPH-1 was treated with 0, 1.25, 2.5, and 5 mg/mL QC for 48 h, respectively. Evaluatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Evid Based Complement Alternat Med
Main Authors: Liu, Liya, Wan, Yun, Shen, Aling, Zhao, Jinyan, Lin, Jiumao, Zhong, Xiaoyong, Zhang, Yuchen, Hong, Zhenfeng
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4534592/
https://ncbi.nlm.nih.gov/pubmed/26294924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/365484
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados